Neuralink is a BCI company founded by Elon Musk. It has announced a significant milestone. The company aims to integrate fully functioning computers and human beings. Its latest device, or implant, named ‘Blindsight’ can restore vision to the blind, claims Elon Musk.
The US Food and Drug Administration (FDA) has designated Neuralink’s experimental Blindsight implant as a “breakthrough device.” This fact is fascinating. This designation is part of the FDA’s voluntary breakthrough devices program. The program aims to accelerate the development and review of innovative medical technologies. These technologies could have a substantial impact on patient care.
The FDA’s breakthrough device designation offers manufacturers a chance to engage closely with FDA experts. This occurs throughout the premarket review process.
This can help address any issues that arise during the development phase more efficiently, potentially speeding up the approval process.
For Neuralink, this designation could significantly accelerate the development of the Blindsight device. This device aims to restore sight to individuals who have lost their vision.
Blindsight is distinct from another Neuralink project known as Telepathy. This project is designed to allow patients with spinal cord injuries to control computers using their thoughts.